NCT04832308 (MiSET-1) is a NA clinical trial of Exercise Therapy in Peripheral Artery Disease, sponsored by Palo Alto Veterans Institute for Research.

Who is sponsoring NCT04832308?

NCT04832308 is sponsored by Palo Alto Veterans Institute for Research.

What drugs are being tested in NCT04832308?

Interventions in NCT04832308: Exercise Therapy.

What condition does NCT04832308 study?

NCT04832308 studies Peripheral Artery Disease, Claudication, Intermittent.

Is NCT04832308 still recruiting?

NCT04832308 is currently withdrawn. Last updated 4 November 2022.

Last reviewed 2022-11-04 · How we verify

NCT04832308: MiSET-1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Intervention Supervised Exercise Therapy Study 1

Withdrawn NA Last updated 4 November 2022

What this trial tests

NA trial testing Exercise Therapy in Peripheral Artery Disease. Withdrawn.

Timeline

20 August 2021

Primary endpoint
1 June 2022

1 June 2022

Quick facts

Lead sponsor	Palo Alto Veterans Institute for Research
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Start date	20 August 2021
Primary completion	1 June 2022
Estimated completion	1 June 2022

Drugs / interventions tested

Exercise Therapy

Conditions studied

Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Claudication, Intermittent — all drugs for Claudication, Intermittent →

Sponsor

Palo Alto Veterans Institute for Research

Who can join

18 and older, any sex, with Peripheral Artery Disease or Claudication, Intermittent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial evaluating the impact of the mobile phone delivered SVS SET Program on utilization, functional capacity, symptoms and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise Therapy

Trials testing the same drug.

NCT07435844 — Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients · NA · not yet recruiting
NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07375823 — Effects of Exercises and Electrical Current Application Aiming to Strengthen Neck and Shoulder Blades Muscles on Symptom · NA · completed
NCT06995534 — Splinting vs Exercise in De Quervain's Tenosynovitis · NA · recruiting
NCT06965985 — Comparison of the Effectiveness of Mulligan Mobilization and Myofascial Release Technique in Patients With Lateral Epico · NA · recruiting

Other recruiting trials for Peripheral Artery Disease

Currently open trials in the same condition.

NCT07374601 — The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease · recruiting
NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting

Other Palo Alto Veterans Institute for Research trials

Trials by the same sponsor.

NCT07219251 — Engagement of Veterans With Lung Cancer · NA · recruiting
NCT06704061 — Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain · NA · recruiting
NCT07069517 — Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD · NA · recruiting
NCT07303725 — Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology · recruiting
NCT07303712 — Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04832308 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Palo Alto Veterans Institute for Research
Last refreshed: 4 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04832308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing